PTPN1 and diabetes mellitus: Kinetic studies proved compounds 89 and 94 to be non-competitive inhibitors with the ability of being developed into highly selective PTP1B inhibitors [64], thus cinnamic acid derivatives can be further explored as PTP1B inhibitors for the treatment of diabetes [13].